Credit Suisse’s Pacific Biosciences PACB Stock Holding History

Credit Suisse’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$1.22M	Buy	325,232 +4,533	+1%	+$17K	﹤0.01%	2143
2023 Q4	$3.15M	Buy	320,699 +49,683	+18%	+$487K	﹤0.01%	1608
2023 Q3	$2.26M	Buy	271,016 +1,218	+0.5%	+$10.2K	﹤0.01%	1743
2023 Q2	$3.59M	Buy	269,798 +44,505	+20%	+$592K	﹤0.01%	1539
2023 Q1	$2.61M	Buy	225,293 +9,645	+4%	+$112K	﹤0.01%	1701
2022 Q4	$1.76M	Sell	215,648 -11,624	-5%	-$95.1K	﹤0.01%	1945
2022 Q3	$1.32M	Buy	227,272 +1,099	+0.5%	+$6.38K	﹤0.01%	2108
2022 Q2	$999K	Sell	226,173 -20,081	-8%	-$88.7K	﹤0.01%	2370
2022 Q1	$2.24M	Buy	246,254 +37,207	+18%	+$339K	﹤0.01%	1987
2021 Q4	$4.28M	Sell	209,047 -45,296	-18%	-$927K	﹤0.01%	1614
2021 Q3	$6.5M	Buy	254,343 +32,716	+15%	+$836K	﹤0.01%	1363
2021 Q2	$7.75M	Sell	221,627 -6,878	-3%	-$241K	﹤0.01%	1278
2021 Q1	$7.61M	Sell	228,505 -47,136	-17%	-$1.57M	﹤0.01%	1311
2020 Q4	$7.15M	Buy	275,641 +116,126	+73%	+$3.01M	﹤0.01%	1298
2020 Q3	$1.57M	Buy	159,515 +25,975	+19%	+$256K	﹤0.01%	1976
2020 Q2	$461K	Sell	133,540 -919,933	-87%	-$3.18M	﹤0.01%	2751
2020 Q1	$3.22M	Buy	1,053,473 +548,503	+109%	+$1.68M	﹤0.01%	1382
2019 Q4	$2.6M	Buy	504,970 +2,287	+0.5%	+$11.8K	﹤0.01%	1864
2019 Q3	$2.59M	Sell	502,683 -407,022	-45%	-$2.1M	﹤0.01%	1772
2019 Q2	$5.51M	Buy	909,705 +271,058	+42%	+$1.64M	﹤0.01%	1286
2019 Q1	$4.62M	Buy	638,647 +380,722	+148%	+$2.75M	﹤0.01%	1378
2018 Q4	$1.91M	Buy	257,925 +199,313	+340%	+$1.47M	﹤0.01%	1844
2018 Q3	$318K	Sell	58,612 -19,415	-25%	-$105K	﹤0.01%	3024
2018 Q2	$277K	Sell	78,027 -3,618	-4%	-$12.8K	﹤0.01%	3192
2018 Q1	$167K	Buy	81,645 +8,791	+12%	+$18K	﹤0.01%	3304
2017 Q4	$191K	Sell	72,854 -36,263	-33%	-$95.1K	﹤0.01%	3257
2017 Q3	$572K	Buy	109,117 +54,402	+99%	+$285K	﹤0.01%	2997
2017 Q2	$195K	Sell	54,715 -10,178	-16%	-$36.3K	﹤0.01%	3239
2017 Q1	$335K	Sell	64,893 -21,229	-25%	-$110K	﹤0.01%	3115
2016 Q4	$327K	Sell	86,122 -34,990	-29%	-$133K	﹤0.01%	3260
2016 Q3	$1.09M	Buy	121,112 +24,408	+25%	+$219K	﹤0.01%	2572
2016 Q2	$680K	Buy	96,704 +27,308	+39%	+$192K	﹤0.01%	2940
2016 Q1	$589K	Buy	69,396 +24,588	+55%	+$209K	﹤0.01%	2842
2015 Q4	$589K	Buy	44,808 +5,730	+15%	+$75.3K	﹤0.01%	3032
2015 Q3	$144K	Sell	39,078 -116,619	-75%	-$430K	﹤0.01%	3814
2015 Q2	$897K	Buy	155,697 +85,232	+121%	+$491K	﹤0.01%	3029
2015 Q1	$411K	Sell	70,465 -62,147	-47%	-$362K	﹤0.01%	3408
2014 Q4	$1.04M	Buy	132,612 +85,737	+183%	+$672K	﹤0.01%	2773
2014 Q3	$230K	Sell	46,875 -62,166	-57%	-$305K	﹤0.01%	3676
2014 Q2	$674K	Sell	109,041 -51,884	-32%	-$321K	﹤0.01%	3204
2014 Q1	$861K	Buy	160,925 +86,914	+117%	+$465K	﹤0.01%	2907
2013 Q4	$387K	Sell	74,011 -78,102	-51%	-$408K	﹤0.01%	3485
2013 Q3	$840K	Buy	152,113 +109,346	+256%	+$604K	﹤0.01%	2700
2013 Q2	$109K	Buy	+42,767	New	+$109K	﹤0.01%	3604